Aller au contenu
Santé cardiovasculaireEssai randomisé4 min read

Wireless home blood pressure cuffs were feasible at a community clinic; no effect conclusion

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Wireless Home Blood Pressure Monitoring With Health Coaching for Hypertension Management at a Federally Qualified Health Center: Pilot Randomized Controlled Feasibility and Acceptability Study. · JMIR formative research · 2026 · Article original ↗

À retenir

In a 6-month pilot at federally qualified health centers, 86% (63/73) of analyzed wireless-arm participants transmitted multiple readings, and 95% (n=57) of 60 survey respondents found the device easy to use. Blood pressure results were exploratory and unpowered, and arm-level allocation counts were not retained, so effectiveness cannot be judged.

Study design

Essai randomisé

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Only about half of adults with hypertension reach blood pressure control, and the gap is larger in low-income and minority groups. Wireless home monitoring may help, but it has been little tested in underserved, mostly Hispanic clinic populations. The authors mainly tested whether wireless monitoring is feasible and acceptable there.

Population et méthode

Two-arm randomized pilot trial lasting 6 months, nested in the San Diego: Heart Attack and Stroke Free Zone program, across 3 federally qualified health center networks. Adults aged 18 or older with uncontrolled or newly diagnosed hypertension (BP of at least 140/90 mm Hg) were randomized 1:1 by simple randomization to wireless monitoring (Bluetooth cuff, cellular hub, weekly summaries reviewed by health coaches) or standard home monitoring with a paper log. Both arms had standardized health coaching. Feasibility was the proportion of 210 expected readings transmitted; acceptability was a satisfaction survey in the wireless arm. BP comparisons were exploratory and limited to participants with more than 2 measurements.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 316 recruited, 290 (92%) were eligible and 200 (63%) were analyzed: 73 wireless and 127 standard. Mean age was 61 years (SD 9.1), 57% (115/200) were women and 51% (n=102) were Hispanic.
  2. 2
    In the wireless arm, 86% (63/73) transmitted multiple readings (mean 160.6, SD 129.1), equal to 76.2% (160/210) of expected readings among transmitters and 66% across all 73. In the standard arm only 5% (7/127) returned paper logs.
  3. 3
    Of 60 respondents (82.2% response rate), 95% (n=57) agreed or strongly agreed that the device was easy to set up and use.
  4. 4
    Both arms had significant within-arm BP reductions at 6 months (P <.001). Systolic BP <140 mm Hg was reached by 63% (46/73) wireless and 74% (94/127) standard (P =.08; adjusted odds ratio, standard vs wireless, 1.6, 95% CI 0.78-3.4; P =.19), which does not show equivalence.

Limites et incertitude

  1. 1
    Only 200 of the randomized participants were analyzed and arm-level allocation counts were not retained, so feasibility among everyone randomized could not be estimated.
  2. 2
    Analysis was limited to participants with more than 2 BP measurements, and many more were analyzed in the standard arm (127) than the wireless arm (73), which can bias the comparison.
  3. 3
    Acceptability came from a survey of 60 wireless-arm respondents only, with no comparison group.
  4. 4
    The authors state the BP comparison was not powered; this reading is based on the abstract only.

Mise en perspective

Wireless blood pressure cuffs can work for many people at community health centers, and most survey respondents found them easy to use. The study does not show whether they lower blood pressure better or worse than a paper log. Changes in blood pressure treatment belong with your clinician.

Vos données

If you use a Bluetooth cuff, regular readings that sync automatically are exactly the data this pilot tested. Use the same cuff, posture and time of day, and bring the weekly average and trend to your appointments rather than single readings.

Comprendre ce type de preuve

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Only approximately half of adults with hypertension, a leading cardiovascular risk factor, achieve blood pressure (BP) control, with persistent disparities among low-income and minority populations. Wireless home BP monitoring (HBPM) with remote patient monitoring can improve BP control, but evidence is limited in medically underserved, predominantly Hispanic populations served by federally qualified health centers (FQHCs).

Objective

The primary objective was to evaluate the feasibility and acceptability of wireless HBPM among predominantly Hispanic adults with hypertension receiving FQHC care. Comparing BP outcomes between wireless and conventional HBPM was a secondary exploratory objective.

Methods

We conducted a 6-month, 2-arm randomized controlled pilot feasibility and acceptability trial nested within the San Diego: Heart Attack and Stroke Free Zone program. Adults aged ≥18 years with uncontrolled or newly diagnosed hypertension (BP ≥140/90 mm Hg) were enrolled across 3 FQHC networks and randomized 1:1 by unrestricted simple randomization to wireless HBPM (Bluetooth cuff and cellular hub; weekly transmitted summaries reviewed by health coaches) or standard HBPM (home monitor with paper log). Both arms received standardized health coaching. The primary outcomes were feasibility (proportion of 210 expected BP readings transmitted) and acceptability (postintervention satisfaction survey in the wireless arm). Exploratory analyses compared BP outcomes between arms among participants with >2 BP measurements.

Results

Of 316 recruited participants, 290 (92%) were eligible, and 200 (63%) were analyzed (wireless: n=73, 23%; and standard: n=127, 40%); arm-level allocation counts were not retained. The mean age was 61 years (SD 9.1), 57% (115/200) were women, and 51% (n=102) self-identified as Hispanic, with no significant baseline differences between arms. Among analyzed wireless-arm participants, 86% (63/73) transmitted multiple readings (mean 160.6, SD 129.1) over 6 months, corresponding to 76.2% (160/210) of expected readings among transmitting participants and 66% across all 73; only 5% (7/127) of standard-arm participants returned paper logs. Of 60 respondents (82.2% response rate), 95% (n=57) agreed or strongly agreed that the device was easy to set up and use. Both arms showed significant within-arm BP reductions at 6 months ( P <.001). At 6 months, 63% (46/73) of the wireless arm and 74% (94/127) of the standard arm achieved systolic BP <140 mm Hg ( P =.08; adjusted odds ratio, standard vs wireless, 1.6, 95% CI 0.78-3.4; P =.19). These exploratory comparisons were not powered and do not constitute evidence of equivalence.

Conclusions

Among analyzed participants, wireless HBPM was feasible, and survey respondents reported high acceptability in a medically underserved, predominantly Hispanic FQHC population. Feasibility among all randomized participants could not be estimated because arm-level allocation counts were not retained. The absence of a between-arm difference in BP control is not evidence of equivalence because this pilot was not powered to compare clinical effectiveness; the BP findings are hypothesis generating.

Sources et attribution

Wireless Home Blood Pressure Monitoring With Health Coaching for Hypertension Management at a Federally Qualified Health Center: Pilot Randomized Controlled Feasibility and Acceptability Study.

Magalit N, Moran R, Narezkina A, Patrick K, DeMaria A.

JMIR formative research · 2026-10-22

DOI: 10.2196/100115 ↗PubMed · 42912953 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Santé cardiovasculaire →